S-M Ji

Summary

Country: China

Publications

  1. ncbi Clinical trial of Tripterygium Wilfordii Hook F. in human kidney transplantation in China
    S M Ji
    Research Institute of Nephrology, Jinling Hospital, and Nanjing University School of Medicine, People s Republic of China
    Transplant Proc 38:1274-9. 2006
  2. ncbi Rescue therapy by immunoadsorption in combination with tacrolimus and mycophenolate mofetil for C4d-positive acute humoral renal allograft rejection
    S M Ji
    Research Institute of Nephrology, Jinling Hospital, Nanjing, China
    Transplant Proc 38:3459-63. 2006
  3. ncbi Immunoregulation of thymosin alpha 1 treatment of cytomegalovirus infection accompanied with acute respiratory distress syndrome after renal transplantation
    S M Ji
    Research Institute of Nephrology, Nanjing, PR China
    Transplant Proc 39:115-9. 2007
  4. ncbi A single-dose daclizumab induction protocol in renal allograft recipients: a Chinese single center experience
    S M Ji
    Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine, 305 East Zhong Shan Road, Nanjing 210002, China
    Transplant Proc 39:1396-401. 2007
  5. ncbi Conversion from cyclosporine to tacrolimus for chronic allograft nephropathy
    S M Ji
    Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine, 305 East Zhong Shan Road, Nanjing 210002, China
    Transplant Proc 39:1402-5. 2007

Detail Information

Publications5

  1. ncbi Clinical trial of Tripterygium Wilfordii Hook F. in human kidney transplantation in China
    S M Ji
    Research Institute of Nephrology, Jinling Hospital, and Nanjing University School of Medicine, People s Republic of China
    Transplant Proc 38:1274-9. 2006
    ..In this study, the effects of Triptergium Wilfordii Hook F.(T II) were assessed on human kidney allograft rejection and long-term survival...
  2. ncbi Rescue therapy by immunoadsorption in combination with tacrolimus and mycophenolate mofetil for C4d-positive acute humoral renal allograft rejection
    S M Ji
    Research Institute of Nephrology, Jinling Hospital, Nanjing, China
    Transplant Proc 38:3459-63. 2006
    ..1 +/- 0.3 mg/dL. Our findings suggested that a therapeutic approach combining IA and TAC and MMF rescue improved the outcomes of AHR...
  3. ncbi Immunoregulation of thymosin alpha 1 treatment of cytomegalovirus infection accompanied with acute respiratory distress syndrome after renal transplantation
    S M Ji
    Research Institute of Nephrology, Nanjing, PR China
    Transplant Proc 39:115-9. 2007
    ..This study suggested that thymosin alpha1 significantly promoted CD4(+) and CD8(+) lymphocytes, repairing cellular immunity and successfully reinforcing resistance to cytomegalovirus disease...
  4. ncbi A single-dose daclizumab induction protocol in renal allograft recipients: a Chinese single center experience
    S M Ji
    Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine, 305 East Zhong Shan Road, Nanjing 210002, China
    Transplant Proc 39:1396-401. 2007
    ..2% and 20.0%, respectively. This study showed that a single-dose of daclizumab effectively prevented acute rejection in Chinese renal allograft recipients...
  5. ncbi Conversion from cyclosporine to tacrolimus for chronic allograft nephropathy
    S M Ji
    Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine, 305 East Zhong Shan Road, Nanjing 210002, China
    Transplant Proc 39:1402-5. 2007
    ..Conversion from a CsA-based regimen to a tacrolimus-based regimen was an effective alterative for salvage of patients with abnormal graft renal function induced by CAN...